C12N 9/2491
Beta-mannosidase , i.e. mannanase
Official title: {Beta-mannosidase (3.2.1.25), i.e. mannanase}
C12N9/2491 (Beta-mannosidase , i.e. mannanase) appears on 44 US grants and 64 published applications in this corpus.
Search patents in C12N- Granted patents
- 44
- Published applications
- 64
- Assignees
- 28
- Inventors
- 168
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 1 |
| 2003 | 1 | 2 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 2 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 1 | 1 |
| 2011 | 0 | 0 |
| 2012 | 1 | 2 |
| 2013 | 0 | 2 |
| 2014 | 3 | 8 |
| 2015 | 3 | 4 |
| 2016 | 2 | 2 |
| 2017 | 2 | 9 |
| 2018 | 3 | 4 |
| 2019 | 4 | 3 |
| 2020 | 0 | 4 |
| 2021 | 2 | 4 |
| 2022 | 3 | 1 |
| 2023 | 3 | 8 |
| 2024 | 2 | 2 |
| 2025 | 4 | 3 |
| 2026 | 4 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Mannanase variants and polynucleotides encoding same16 Jun 2026US 12,655,368 B2Novozymes A/S
- Mannanase variants7 Apr 2026US 12,595,472 B2BASF SE
- Mannanase variants10 Feb 2026US 12,545,860 B2BASF SE
- Mannanase variants27 Jan 2026US 12,534,735 B2BASF SE
- Mannanase variants and polynucleotides encoding same16 Dec 2025US 12,497,606 B2Novozymes A/S
- Mannanase variants and polynucleotides encoding same20 Aug 2026US 2026/0242701 A1Novozymes A/S
- Transcriptional regulators and polynucleotides encoding the same21 May 2026US 2026/0139260 A1Novozymes A/S
- Mannanase Variants and Polynucleotides Encoding Same12 Mar 2026US 2026/0071200 A1Novozymes A/S
- Cleaning Compositions and Uses Thereof21 Aug 2025US 2025/0263638 A1Novozymes A/S
- Glycosyl hydrolase enzymes in high temperature industrial processes29 May 2025US 2025/0171681 A1Advanced Enzyme Systems, LLC
Most cited
By later US patents
- Mannanases52US 6,566,114 B1Novozymes A/S · 2003
- Enzyme exhibiting mannase activity, cleaning compositions, and methods of use25US 6,060,299 ANovo Nordisk A/S · 2000
- Structured liquid compositions13US 10,100,269 B2The Procter & Gamble Company · 2018
- Structured liquid compositions11US 9,534,191 B2The Procter & Gamble Company · 2017
- Mannanases10US 7,183,093 B2Novozymes A/S · 2007